摘要
1例35岁有明显流行病学接触史女性患者,因右眼急性睑板腺炎首诊于眼科,而后相继出现结膜下出血、发热和咳嗽等症状,经过了局部抗生素药物治疗和全身抗病毒药物治疗。随后其否认任何流行病接触史的母亲和父亲均先后出现发热乏力等症状,诊断为2019新型冠状病毒肺炎(COVID-19)。患者在眼科首诊后17 d经肺部CT检查发现肺部COVID-19改变,于眼科首诊后24 d第3次的鼻咽拭子病毒核酸检测显示阳性,最终确诊为COVID-19,入住方舱医院隔离治疗。目前,COVID-19眼部感染情况尚不明确,症状表现多样化,医务人员对首诊眼科的患者应保持警惕并注意防护。
A 35-year-old female patient with a history of significant epidemiological exposure firstly visited eye doctor due to acute tarsadenitis in the right eye.Subsequently,she developed subconjunctival hemorrhage,fever and cough and received topical administration of antibiotics and systemic treatment of antiviral drug.Shortly thereafter,both his mother and father,who denied COVID-19 associated epidemiological history,appeared fever,fatigue and other symptoms and diagnosed as COVID-19.This female patient was diagnosed as COVID-19 by CT image of lung and COVID-19 RNA detection 17 days and 24 days after firstly visited eye doctor,respectively,and received specialized isolation treatment.The symptoms of COVID-19 are very varied,eye doctors should keep alert and pay attention to personal protection.
作者
徐曼
张宏达
牛晓光
Xu Man;Zhang Hongda;Niu Xiaoguang(Wuhan Aier Ophthalmic Hanyang Hospital,430050)
出处
《中华实验眼科杂志》
CAS
CSCD
北大核心
2020年第4期374-376,共3页
Chinese Journal Of Experimental Ophthalmology
关键词
新型冠状病毒肺炎
睑板腺炎
结膜下出血
2019新型冠状病毒
疫情防控
Novel corona virus disease
Tarsadenitis
Subconjunctival hemorrhage
2019 Novel coronavirus
Prevention and control of epidemic